NCT06669364View on ClinicalTrials.gov

A Retrospective Study to Validate BioEP as an Assessment Aid for Seizure Susceptibility

Not yet recruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

March 1, 2025

Study Completion Date

March 1, 2025

Conditions
Epilepsy
Sponsors

Lead Sponsor

Neuronostics Ltd
All Listed Sponsors
lead

Neuronostics Ltd

INDUSTRY

NCT06669364 - A Retrospective Study to Validate BioEP as an Assessment Aid for Seizure Susceptibility | Biotech Hunter | Biotech Hunter